Literature DB >> 9657264

Anti-Lewis X antibody and Lewis X-anti-Lewis X immune complexes in Helicobacter pylori infection.

M Chmiela1, T Wadstrom, H Folkesson, I Płaneta Małecka, E Czkwianianc, T Rechciński, W Rudnicka.   

Abstract

A molecular similarity of Lewis antigens expressed by Helicobacter pylori bacteria and those present in human gastric mucosa has been recognised as a cause of autoimmunity involved in the pathogenesis of chronic type B gastritis and gastric and duodenal ulcers. In this study, the expression of Lewis X determinants was found on 56% of H. pylori strains isolated from patients with chronic gastritis/gastroduodenitis. Anti-Lewis X IgG as well as Lewis X-anti-Lewis X IgG complexes were detected in the sera from patients and even more frequently in the sera from healthy blood donors producing antibodies against surface antigens of H. pylori. It suggested that the initial H. pylori-induced lesions were independent of anti-Lewis X antibody production. When H. pylori bacteria expressing Lewis X antigen were treated with anti-Lewis X monoclonal antibody (mAb) of IgM isotype, they were more susceptible to ingestion by polymorphonuclear leukocytes (PMN) than untreated bacteria. This fact may lead us to believe that anti-Lewis X antibody limits the growth of H. pylori on gastric mucosa.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9657264     DOI: 10.1016/s0165-2478(98)00004-2

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  8 in total

1.  Relationship of anti-Lewis x and anti-Lewis y antibodies in serum samples from gastric cancer and chronic gastritis patients to Helicobacter pylori-mediated autoimmunity.

Authors:  M A Heneghan; C F McCarthy; D Janulaityte; A P Moran
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

2.  Syntheses of Lewis(x) and dimeric Lewis(x): construction of branched oligosaccharides by a combination of preactivation and reactivity based chemoselective one-pot glycosylations.

Authors:  Adeline Miermont; Youlin Zeng; Yuqing Jing; Xin-shan Ye; Xuefei Huang
Journal:  J Org Chem       Date:  2007-10-16       Impact factor: 4.354

Review 3.  Structural modifications of Helicobacter pylori lipopolysaccharide: an idea for how to live in peace.

Authors:  Magdalena Chmiela; Eliza Miszczyk; Karolina Rudnicka
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

4.  Fluorous-Assisted One-Pot Oligosaccharide Synthesis.

Authors:  Bo Yang; Yuqing Jing; Xuefei Huang
Journal:  European J Org Chem       Date:  2010-01-27

Review 5.  Molecular mimicry in Helicobacter pylori infections.

Authors:  Magdalena Chmiela; Weronika Gonciarz
Journal:  World J Gastroenterol       Date:  2017-06-14       Impact factor: 5.742

6.  Upregulation of MUC5AC production and deposition of LEWIS determinants by HELICOBACTER PYLORI facilitate gastric tissue colonization and the maintenance of infection.

Authors:  Weronika Gonciarz; Maria Walencka; Anthony P Moran; Krzysztof Hinc; Michał Obuchowski; Magdalena Chmiela
Journal:  J Biomed Sci       Date:  2019-03-06       Impact factor: 8.410

Review 7.  Helicobacter pylori Virulence Factors-Mechanisms of Bacterial Pathogenicity in the Gastric Microenvironment.

Authors:  Jacek Baj; Alicja Forma; Monika Sitarz; Piero Portincasa; Gabriella Garruti; Danuta Krasowska; Ryszard Maciejewski
Journal:  Cells       Date:  2020-12-25       Impact factor: 6.600

8.  The glycosphingolipid P₁ is an ovarian cancer-associated carbohydrate antigen involved in migration.

Authors:  F Jacob; M Anugraham; T Pochechueva; B W C Tse; S Alam; R Guertler; N V Bovin; A Fedier; N F Hacker; M E Huflejt; N Packer; V A Heinzelmann-Schwarz
Journal:  Br J Cancer       Date:  2014-08-28       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.